RP-L201
RP-L201-0318
Phase 2 mab completed
Quick answer
RP-L201 for Leukocyte Adhesion Defect - Type I is a Phase 2 program (mab) at ROCKET PHARMACEUTICALS, INC. with 2 ClinicalTrials.gov record(s).
Program details
- Company
- ROCKET PHARMACEUTICALS, INC.
- Indication
- Leukocyte Adhesion Defect - Type I
- Phase
- Phase 2
- Modality
- mab
- Status
- completed